PAPER Gold G, Kövari E, Corte G, Herrmann FR, Canuto A, Bussière T, Hof PR, Bouras C, Giannakopoulos P
SEARCH RESULTS
331764 RESULTS
PAPER
Alzheimer's Disease versus other Degenerative Dementias: from Biology to Treatment. Proceedings of a meeting. Perugia, Italy, June 17, 2000.
Mech Ageing Dev. 2001 Nov;122(16):1923-35. PubMed: 11589910PAPER Sjögren M, Wallin A
Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.
Mech Ageing Dev. 2001 Nov;122(16):1923-35. PubMed: 11589911PAPER Sorbi S, Forleo P, Tedde A, Cellini E, Ciantelli M, Bagnoli S, Nacmias B
Genetic risk factors in familial Alzheimer's disease.
Mech Ageing Dev. 2001 Nov;122(16):1951-60. PubMed: 11589913PAPER Talesa VN
Acetylcholinesterase in Alzheimer's disease.
Mech Ageing Dev. 2001 Nov;122(16):1961-9. PubMed: 11589914PAPER Bergamaschini L, Donarini C, Gobbo G, Parnetti L, Gallai V
Activation of complement and contact system in Alzheimer's disease.
Mech Ageing Dev. 2001 Nov;122(16):1971-83. PubMed: 11589915PAPER De Luigi A, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, Grazia De Simoni M
Inflammatory markers in Alzheimer's disease and multi-infarct dementia.
Mech Ageing Dev. 2001 Nov;122(16):1985-95. PubMed: 11589916PAPER Padovani A, Borroni B, Colciaghi F, Pastorino L, Archetti S, Cottini E, Caimi L, Cattabeni F, Di Luca M
Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target.
Mech Ageing Dev. 2001 Nov;122(16):1997-2004. PubMed: 11589917PAPER Vanmechelen E, Vanderstichele H, Hulstaert F, Andreasen N, Minthon L, Winblad B, Davidsson P, Blennow K
Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders.
Mech Ageing Dev. 2001 Nov;122(16):2005-11. PubMed: 11589918PAPER Amenta F, Parnetti L, Gallai V, Wallin A
Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?
Mech Ageing Dev. 2001 Nov;122(16):2025-40. PubMed: 11589920PAPER Parnetti L, Amenta F, Gallai V
Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
Mech Ageing Dev. 2001 Nov;122(16):2041-55. PubMed: 11589921PAPER Amici S, Lanari A, Romani R, Antognelli C, Gallai V, Parnetti L
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina.
Mech Ageing Dev. 2001 Nov;122(16):2057-62. PubMed: 11589922PAPER Lendon C, Craddock N
Is LBP-1c/CP2/LSF a disease-modifying gene for Alzheimer's disease?
Lancet. 2001 Sep 29;358(9287):1029-30. PubMed: 11589929PAPER Golde TE, Eckman CB
Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease.
Drug Discov Today. 2001 Oct 15;6(20):1049-1055. PubMed: 11590033PAPER O'Brien HL, Tetewsky SJ, Avery LM, Cushman LA, Makous W, Duffy CJ